Sutro Biopharma is a smaller ADC (antibody-drug conjugate) player with a proven technology platform and multiple pharma ...
New phase 3 results should reopen discussion about the off-label use of COMT inhibitors in early Parkinson's disease, experts ...
More than half of peer reviewers for four top medical journals received payments from drug and medical device manufacturers, ...
Some cancers occurred more frequently in people with multiple sclerosis (MS) than in others, a retrospective study in France ...
The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life ...
Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women’s Hospital, a founding member of the ...
Brussels, Belgium, 8 October 2024. A groundbreaking study led by Dr Monika E. Hegi, MD, PhD and European Organisation for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc, ...
Medpage Today on MSN10d
Selective Role for Single-Agent Ipilimumab After Anti-PD-1 Failure in MelanomaPatients with wild-type metastatic melanoma that progressed on frontline PD-1 inhibition had almost a 2-year median overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback